Dr. Gutierrez currently serves as the head of Covance’s Neuroscience therapeutic area. In this role, he has oversight for all studies in Neuroscience conducted by Covance across the globe. Dr. Gutierrez previously held positions in the Neuroscience franchises at J&J, Novartis and BMS where he had worldwide responsibility for the development of compounds in both psychiatric and neurologic indications. He has more than 20 years of pharmaceutical development experience in Clinical Development, Project Management and Medical Affairs. He has led or supervised the development of compounds in a range of neuroscience indications, including rare and orphan diseases.